Abstract
No public abstract is available from the verified source records.
Samuel J Mann
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2025
Sympathetic overactivation in the resistant hypertensive phenotype: a meta-analysis of published studies
10.1161/hypertensionaha.125.24749 · 2025
Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects
1979
Clinical pharmacokinetics and pharmacodynamics of carvedilol
10.2165/00003088-199426050-00002 · 1994
Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines
10.2165/00003088-200241070-00004 · 2002
Carvedilol and bisoprolol as initial therapy for adult hypertension without compelling indications
10.1038/s41440-018-0174-6 · 2019
Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study
10.2165/00003495-198800366-00015 · 1988
Low-dose alpha/beta blockade in the treatment of essential hypertension
10.1016/s0895-7061(00)01302-9 · 2001
Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial
10.1007/bf00315116 · 1990
The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by beta-blockers
10.1016/0002-8703(91)90864-e · 1991
Concomitant administration of terazosin and atenolol for the treatment of essential hypertension
10.1001/archinte.1988.00380030045010 · 1988
Beta-blockers are not all the same: pharmacologic similarities and differences, potential combinations and clinical implications
10.1080/03007995.2024.2318058 · 2024
Clinical pharmacology of doxazosin in patients with essential hypertension
10.1038/clpt.1987.54 · 1987
Efficacy and safety of renal denervation for the management of arterial hypertension: a systematic review and meta-analysis of randomized, sham-controlled, catheter-based trials
10.1111/jch.13827 · 2020
No additional external references are available.